← Back to Search

Digital Health Intervention

Telemonitoring for Heart Failure (Medly-AID Trial)

N/A
Waitlist Available
Led By Emily Seto, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (18 years or older)
Hospitalization for decompensated HF > 48 hours
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month, 3 months
Awards & highlights

Medly-AID Trial Summary

This trial will test a new smartphone app, Medly, for patients recently diagnosed with heart failure. The app is designed to help manage self-care and improve quality of life. The trial will measure if the app leads to a reduction in 30-day readmissions rates, without increasing the average length of stay or visits to the emergency department.

Who is the study for?
This trial is for adults over 18 who've been hospitalized for heart failure longer than 48 hours. They must speak and read English (or have a caregiver who can translate) to use the Medly app, which monitors their condition after discharge. People with dementia, psychiatric illnesses, terminal conditions, or those in long-term care or other trials cannot join.Check my eligibility
What is being tested?
The study tests if using the Medly telemonitoring system improves self-care and quality of life for heart failure patients post-discharge. It also checks if Medly reduces hospital readmissions within 30 days without increasing emergency visits or hospital stay lengths.See study design
What are the potential side effects?
Since this trial involves monitoring through an app rather than medication, traditional side effects are not expected. However, there may be indirect effects related to stress from technology use or data privacy concerns.

Medly-AID Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I was hospitalized for heart failure symptoms for more than 48 hours.

Medly-AID Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month, 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change BNP/NT-pro BNP levels
Change in NYHA class
Change in quality of life
+2 more
Secondary outcome measures
30-day HF readmission rate
Hospital length of stay
Number of visits to the emergency department
Other outcome measures
Safety Endpoint: Change in creatinine levels
Safety Endpoint: Change in potassium levels
Safety Endpoint: Change in sodium levels

Medly-AID Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telemonitoring (Medly)Experimental Treatment1 Intervention
Medly is a smartphone application allows heart failure (HF) patients to measure and record their daily weight, blood pressure (BP), heart rate, and self-reported symptoms. This monitoring information is then transmitted wirelessly to a data server where an algorithm is used to generate an alert to a healthcare provider as necessary. The patient also receives an automated self-care message based on their measurements and reported symptoms.
Group II: ControlActive Control1 Intervention
Standard of care: Control groups will receive standard medical care when discharged from hospital, including discharge instructions, home medications as well as follow-up in a heart failure clinic or with a primary care doctor.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medly
2016
N/A
~100

Find a Location

Who is running the clinical trial?

North York General HospitalOTHER
20 Previous Clinical Trials
8,795 Total Patients Enrolled
University Health Network, TorontoLead Sponsor
1,456 Previous Clinical Trials
482,709 Total Patients Enrolled
25 Trials studying Heart Failure
17,432 Patients Enrolled for Heart Failure
Sunnybrook Health Sciences CentreOTHER
651 Previous Clinical Trials
1,542,599 Total Patients Enrolled
5 Trials studying Heart Failure
46,664 Patients Enrolled for Heart Failure

Media Library

Telemonitoring (Digital Health Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03358303 — N/A
Heart Failure Research Study Groups: Telemonitoring (Medly), Control
Heart Failure Clinical Trial 2023: Telemonitoring Highlights & Side Effects. Trial Name: NCT03358303 — N/A
Telemonitoring (Digital Health Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03358303 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of enrollees for this clinical investigation?

"Affirmative. Based on the information available from clinicaltrials.gov, this research venture is recruiting participants as we speak. The trial was first uploaded in November 2018 and has been updated just recently in March 2022; it is seeking 144 volunteers across 4 sites for involvement."

Answered by AI

Are there any opportunities for recruitment in this clinical trial?

"According to the information stored on clinicaltrials.gov, this trial is currently in need of participants and was created on November 16th 2018 before being amended most recently on March 9th 2022."

Answered by AI
Recent research and studies
~14 spots leftby Mar 2025